Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what national guidance is in place for cases of aspirin-allergic women at high risk of placental complications.

NHS England’s guidance states that there are a few absolute contraindications, that being, conditions that mean a certain treatment should not be used, to aspirin therapy. Pregnant women with a history of aspirin allergy, for example urticaria, or hypersensitivity to other salicylates are at risk of anaphylaxis and should not receive aspirin. Clinicians should undertake a personalised risk assessment and agree appropriate care and surveillance of maternal and foetal health in line with national guidance, local protocols, and the woman’s circumstances. NHS England’s guidance is available at the following link:

https://www.england.nhs.uk/long-read/saving-babies-lives-version-3-2/#appendix-b-medication-to-reduce-the-risk-of-pregnancy-complications:~:text=There%20are%20a%20few,case%2Dby%2Dcase%20basis